Data as of 1:25pm ET
| +0.23 / +2.65%|
The 5 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 17.00, with a high estimate of 17.00 and a low estimate of 13.00. The median estimate represents a +91.01% increase from the last price of 8.90.
The current consensus among 6 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.